Mannase gene VbMan26A, recombinant plasmid, recombinant strain, mannase and application thereof
A technology of mannase and recombinant plasmid, applied in the field of genetic engineering, can solve the problems such as rare mannase, and achieve the effect of high activity
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0049] The acquisition of embodiment 1 mannosidase gene VbMan26A
[0050] With the protein sequence (UniProtKB number: A2QKT4) of Aspergillus niger (Aspergillus Niger BK01) mannosidase as query sequence, search the GenBank protein sequence resource bank with the Blastp program, find the mannosidase gene involved in the present invention; The preference of the mannosidase gene codon was optimized and designed to obtain the mannosidase gene VbMan26A, the nucleotide sequence of which is shown in SEQ ID NO:1. Mannosidase gene VbMan26A was synthesized in Suzhou Jinweizhi Co., Ltd. The synthetic mannosidase gene VbMan26A was located on the pU57 vector, and the 5' end and 3' end of the synthetic gene had restriction enzyme cutting sites BamH 1 and Xho 1.
Embodiment 2
[0051] The preparation of embodiment 2 recombinant plasmids
[0052] (1) cutting the mannosidase gene VbMan26A obtained in Example 1 from the pU57 vector with restriction endonucleases BamH 1 and Xho 1 (both purchased from Takara Company), and cutting the gel to recover the cut VbMan26A DNA fragment;
[0053] (2) The VbMan26A DNA fragment was connected to the pET-28a vector (a commercial vector for recombinant expression of foreign genes in Escherichia coli, purchased from Novagen) by T4 DNA ligase (purchased from Takara Company). with kanamycin resistance gene);
[0054] (3) pass the connection product through CaCl 2 coli DH5α (a conventional cloning strain in a biological laboratory, purchased from Invitrogen, and stored in the laboratory of Wuhan University of Light Industry) competent cells. The transformed cells were coated on LB agar plates containing 100 μg / mL kanamycin (purchased from Sigma) for positive transformant screening; the preparation of E. coli DH5α compete...
Embodiment 3
[0056] The preparation of embodiment 3 recombinant strains
[0057] (1) The recombinant plasmid pET-28a-VbMan26A that embodiment 2 obtains adopts CaCl 2 coli BL21 (Rosetta) (purchased from Novagen, which is a common gene engineering expression bacterium in the laboratory, which has chloramphenicol resistance and is stored in the laboratory of Wuhan University of Light Industry) competent cells; The preparation and transformation method of state Escherichia coli BL21 (Rosetta) are identical with the method in embodiment 2 step (3);
[0058] (2) Spread the transformed Escherichia coli BL21 (Rosetta) on the LB agar plate containing kanamycin (100 μg / mL) and chloramphenicol (34 μg / mL, purchased from Sigma Company), where the double antibody The colonies grown on the sex plate were recombinant strains.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com